vs

Side-by-side financial comparison of Moolec Science SA (MLEC) and Palladyne AI Corp. (PDYN). Click either name above to swap in a different company.

Moolec Science SA is the larger business by last-quarter revenue ($2.6M vs $1.7M, roughly 1.6× Palladyne AI Corp.). Palladyne AI Corp. runs the higher net margin — -89.9% vs -91.8%, a 2.0% gap on every dollar of revenue.

Moolec Science SA is a global agricultural biotechnology and food technology company specializing in molecular farming. It uses engineered crop platforms to produce sustainable, cost-competitive animal-derived proteins for use in alternative meat, dairy products and food ingredients, serving food manufacturers, agribusinesses and consumer goods brands across North America, Europe and Latin America.

Palladyne AI Corp. is an American company known for most of its existence primarily as a developer of robots. Palladyne was founded in 1983 as Sarcos Research Corporation. In 2023, Sarcos shifted its business focus to the development of artificial intelligence (AI) software for robotic applications, discontinuing its hardware operations. In March 2024, the company changed its name to Palladyne AI.

MLEC vs PDYN — Head-to-Head

Bigger by revenue
MLEC
MLEC
1.6× larger
MLEC
$2.6M
$1.7M
PDYN
Higher net margin
PDYN
PDYN
2.0% more per $
PDYN
-89.9%
-91.8%
MLEC

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
MLEC
MLEC
PDYN
PDYN
Revenue
$2.6M
$1.7M
Net Profit
$-2.4M
$-1.5M
Gross Margin
-25.5%
15.6%
Operating Margin
-77.9%
-560.7%
Net Margin
-91.8%
-89.9%
Revenue YoY
118.3%
Net Profit YoY
97.2%
EPS (diluted)
$-0.06
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MLEC
MLEC
PDYN
PDYN
Q4 25
$1.7M
Q3 25
$860.0K
Q2 25
$1.0M
Q1 25
$1.7M
Q4 24
$2.6M
$761.0K
Q3 24
$871.0K
Q2 24
$2.7M
Q1 24
$3.4M
Net Profit
MLEC
MLEC
PDYN
PDYN
Q4 25
$-1.5M
Q3 25
$-3.7M
Q2 25
$-7.5M
Q1 25
$22.8M
Q4 24
$-2.4M
Q3 24
$-7.1M
Q2 24
$-5.3M
Q1 24
$-7.2M
Gross Margin
MLEC
MLEC
PDYN
PDYN
Q4 25
15.6%
Q3 25
46.4%
Q2 25
53.3%
Q1 25
79.4%
Q4 24
-25.5%
27.2%
Q3 24
45.0%
Q2 24
79.0%
Q1 24
45.2%
Operating Margin
MLEC
MLEC
PDYN
PDYN
Q4 25
-560.7%
Q3 25
-937.8%
Q2 25
-797.4%
Q1 25
-405.3%
Q4 24
-77.9%
Q3 24
-838.0%
Q2 24
-213.3%
Q1 24
-213.7%
Net Margin
MLEC
MLEC
PDYN
PDYN
Q4 25
-89.9%
Q3 25
-434.9%
Q2 25
-737.6%
Q1 25
1330.9%
Q4 24
-91.8%
Q3 24
-814.7%
Q2 24
-196.2%
Q1 24
-210.1%
EPS (diluted)
MLEC
MLEC
PDYN
PDYN
Q4 25
$-0.02
Q3 25
$-0.09
Q2 25
$-0.20
Q1 25
$0.55
Q4 24
$-0.06
Q3 24
$-0.27
Q2 24
$-0.20
Q1 24
$-0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MLEC
MLEC
PDYN
PDYN
Cash + ST InvestmentsLiquidity on hand
$1.9M
$47.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.8M
$74.7M
Total Assets
$31.4M
$95.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MLEC
MLEC
PDYN
PDYN
Q4 25
$47.1M
Q3 25
$57.1M
Q2 25
$62.7M
Q1 25
$46.6M
Q4 24
$1.9M
$40.1M
Q3 24
$21.3M
Q2 24
$25.8M
Q1 24
$31.8M
Stockholders' Equity
MLEC
MLEC
PDYN
PDYN
Q4 25
$74.7M
Q3 25
$51.8M
Q2 25
$53.8M
Q1 25
$28.3M
Q4 24
$2.8M
$-9.5M
Q3 24
$23.4M
Q2 24
$29.8M
Q1 24
$34.2M
Total Assets
MLEC
MLEC
PDYN
PDYN
Q4 25
$95.7M
Q3 25
$72.9M
Q2 25
$78.3M
Q1 25
$63.3M
Q4 24
$31.4M
$56.3M
Q3 24
$38.7M
Q2 24
$45.1M
Q1 24
$50.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MLEC
MLEC
PDYN
PDYN
Operating Cash FlowLast quarter
$-8.5M
Free Cash FlowOCF − Capex
$-8.7M
FCF MarginFCF / Revenue
-526.2%
Capex IntensityCapex / Revenue
4.4%
14.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MLEC
MLEC
PDYN
PDYN
Q4 25
$-8.5M
Q3 25
$-6.3M
Q2 25
$-5.3M
Q1 25
$-7.5M
Q4 24
$-22.6M
Q3 24
$-4.5M
Q2 24
$-5.8M
Q1 24
$-7.2M
Free Cash Flow
MLEC
MLEC
PDYN
PDYN
Q4 25
$-8.7M
Q3 25
$-6.7M
Q2 25
Q1 25
$-7.6M
Q4 24
$-22.9M
Q3 24
$-4.5M
Q2 24
$-5.9M
Q1 24
$-7.3M
FCF Margin
MLEC
MLEC
PDYN
PDYN
Q4 25
-526.2%
Q3 25
-776.0%
Q2 25
Q1 25
-445.0%
Q4 24
-3008.1%
Q3 24
-517.8%
Q2 24
-218.9%
Q1 24
-212.1%
Capex Intensity
MLEC
MLEC
PDYN
PDYN
Q4 25
14.2%
Q3 25
44.7%
Q2 25
0.0%
Q1 25
5.4%
Q4 24
4.4%
34.8%
Q3 24
1.4%
Q2 24
5.3%
Q1 24
1.8%
Cash Conversion
MLEC
MLEC
PDYN
PDYN
Q4 25
Q3 25
Q2 25
Q1 25
-0.33×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons